{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:28:05Z","timestamp":1790220485504,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T00:00:00Z","timestamp":1120435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The graft\u2010<jats:italic>versus<\/jats:italic>\u2010host disease (GVHD) characteristics of 150 consecutive patients undergoing reduced intensity conditioning allogeneic (allo\u2010RIC) transplants and 88 patients undergoing myeloablative conditioning regimen were analysed. All patients received the same GVHD prophylaxis and peripheral blood stem cells from a human leucocyte antigen identical sibling. The cumulative incidence of acute GVHD (aGVHD) was 67% and 44% in the myeloablative and allo\u2010RIC regimen groups, respectively (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001), and was 39% vs. 29%, respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7043), for grades 2\u20134 aGVHD. Only conditioning type (myeloablative <jats:italic>versus<\/jats:italic> allo\u2010RIC) significantly influenced the incidence of aGVHD in multivariate analysis: Hazard ratio (HR)\u2003=\u20032\u00b716 [95% confidence interval (CI): 1\u00b752\u20133\u00b707], <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001. The cumulative incidence of chronic GVHD (cGVHD) was 63% and 71% among myeloablative and allo\u2010RIC patients respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7084). This trend was because of the higher incidence of limited cGVHD, but not extensive cGVHD among allo\u2010RIC recipients [HR\u2003=\u20033\u00b73 (95% CI: 1\u00b742\u20138\u00b708), <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b70017]. Moreover, among patients who developed cGVHD, the cumulative incidence of limited cGVHD was significantly lower in the myeloablative group than in the allo\u2010RIC group (7% vs. 25%, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7007). Duration of immunosuppression was shorter among allo\u2010RIC patients (35\u00b75% vs. 68\u00b78% required systemic immunosuppression 36\u2003months after transplant, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7028). Although prospective controlled trials are required to further evaluate the effect of the conditioning regimen on GVHD, our results suggest that RIC modifies the incidence and characteristics of both acute and cGVHD after allogeneic transplantation, and decreases the immunosuppression requirements in long\u2010term follow up when compared with myeloablative conditioning.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05614.x","type":"journal-article","created":{"date-parts":[[2005,7,21]],"date-time":"2005-07-21T22:22:00Z","timestamp":1121984520000},"page":"394-403","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft\u2010<i>versus<\/i>\u2010host disease after allogeneic transplantation"],"prefix":"10.1111","volume":"130","author":[{"given":"Jos\u00e9 A.","family":"P\u00e9rez\u2010Sim\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"D\u00edez\u2010Campelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salut","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda D.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Valc\u00e1rcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Del Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"L\u00f3pez\u2010Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas F.","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,4]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1219"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3141"},{"key":"e_1_2_5_4_1","article-title":"A prospective randomized trial comparing cyclosporine + short course methotrexate to cyclosporine\u2003+\u2003mycophenolate for GVHD prophylaxis in ablative allogeneic BMT","volume":"102","author":"Bolwell B.J.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1455"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1182\/blood.V88.12.4601.bloodjournal88124601","article-title":"Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the V \u03b2T\u2010cell receptor repertoire by both host and donor bone marrow\u2010derived cells","volume":"88","author":"Colson Y.L.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4285"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2003.10.006"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(99)70011-X"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0011"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704142"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2424"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1597"},{"key":"e_1_2_5_14_1","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells wirrh purine analog\u2010containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy","volume":"89","author":"Giralt S.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(00)00677-9"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.8.3204"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3868"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2043"},{"key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH\u20101H prevents graft\u2010versus\u2010host disease following non myeloablative stem cell transplantation","volume":"96","author":"Kottaridis P.D.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.11.3409.3409"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199807150-00015"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703150"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03153.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0400"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.1999.v5.pm10465099"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3390"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2628"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.9.3128"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.7.1838.1838"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.2.405"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402550"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04237.x"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3503"},{"key":"e_1_2_5_35_1","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_5_36_1","article-title":"Non\u2010myeloablative stem cell transplantation is associated with reduced inflammatory cytokine storm and a decreased incidence of acute graft\u2010versus\u2010host disease compared to myeloablative stem cell transplantation","volume":"102","author":"Reddy V.","year":"2003","journal-title":"Blood"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5426.412"},{"key":"e_1_2_5_38_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with letal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin S.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402521"},{"key":"e_1_2_5_40_1","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA\u2010identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.2.267.267"},{"key":"e_1_2_5_42_1","first-page":"250","article-title":"Chronic graft\u2010versus\u2010host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan K.M.","year":"1991","journal-title":"Seminars in Hematology"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00075200-200109000-00012"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199106000-00010"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3584"},{"key":"e_1_2_5_46_1","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan\u2010cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft\u2010versus\u2010host disease in H\u20102\u2010incompatible transplanted SCID mice","volume":"83","author":"Xun C.Q.","year":"1994","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05614.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05614.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:55:38Z","timestamp":1697392538000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05614.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,4]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05614.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05614.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,4]]},"assertion":[{"value":"2005-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}